VOTING AGREEMENT, dated as of June 20, 2010 (this “Agreement”), among Biovail Corporation, a Canadian corporation (“Biovail”), Valeant Pharmaceuticals International, a Delaware corporation (“Delaware”) and the party listed on Schedule A hereto (the...Voting Agreement • June 23rd, 2010 • BIOVAIL Corp • Pharmaceutical preparations • Delaware
Contract Type FiledJune 23rd, 2010 Company Industry JurisdictionWHEREAS, Biovail, Valeant, Biovail Americas Corp., a direct, wholly owned subsidiary of Biovail (“BAC”), and Beach Merger Corp., a direct, wholly owned subsidiary of BAC (“Merger Sub”), propose to enter into an Agreement and Plan of Merger dated as of the date hereof (as the same may be amended or supplemented, the “Merger Agreement”; capitalized terms used but not defined herein shall have the meanings set forth in the Merger Agreement) providing for the merger of Merger Sub with and into Valeant; and
AGREEMENT AND PLAN OF MERGER Dated as of June 20, 2010, Among Valeant Pharmaceuticals International, Biovail Corporation, Biovail Americas Corp. and Beach Merger Corp.Merger Agreement • June 23rd, 2010 • BIOVAIL Corp • Pharmaceutical preparations • Delaware
Contract Type FiledJune 23rd, 2010 Company Industry JurisdictionAGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of June 20, 2010, among Valeant Pharmaceuticals International, a Delaware corporation (“Valeant”), Biovail Corporation, a Canadian corporation (“Biovail”), Biovail Americas Corp., a Delaware corporation and a wholly owned subsidiary of Biovail (“BAC”), and Beach Merger Corp., a Delaware corporation and a newly formed, wholly owned subsidiary of BAC (“Merger Sub”).
BIOVAIL CORPORATION EMPLOYMENT AGREEMENTEmployment Agreement • June 23rd, 2010 • BIOVAIL Corp • Pharmaceutical preparations • New Jersey
Contract Type FiledJune 23rd, 2010 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”) is hereby entered into as of June 20, 2010 by and between Biovail Corporation (the “Company”), Biovail Laboratories International SRL (“BLS”) and J. Michael Pearson, an individual (the “Executive”) (hereinafter collectively referred to as “the parties”) and shall be effective as of the “Effective Date” (as hereinafter defined).